In addition, mutations and autoantibodies that interfere with IFN-related pathways, including virus RNA sensing, IFN production, and response, have been identified in severe COVID-19 cases and shown to be correlated with poor outcomes (115, 116). Here, IFNA1 is linked to COVID-19.